Compare RIVN & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RIVN | WST |
|---|---|---|
| Founded | 2009 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.6B | 23.9B |
| IPO Year | 2021 | 2004 |
| Metric | RIVN | WST |
|---|---|---|
| Price | $14.08 | $368.57 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 25 | 17 |
| Target Price | $19.00 | ★ $412.25 |
| AVG Volume (30 Days) | ★ 18.0M | 452.0K |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.24% |
| EPS Growth | ★ 34.54 | 1.49 |
| EPS | N/A | ★ 4.07 |
| Revenue | ★ $5,387,000,000.00 | $2,886,900,000.00 |
| Revenue This Year | $38.02 | $9.79 |
| Revenue Next Year | $57.42 | $6.28 |
| P/E Ratio | ★ N/A | $89.26 |
| Revenue Growth | ★ 8.39 | 1.95 |
| 52 Week Low | $12.39 | $223.83 |
| 52 Week High | $22.69 | $386.00 |
| Indicator | RIVN | WST |
|---|---|---|
| Relative Strength Index (RSI) | 33.05 | 54.49 |
| Support Level | $13.58 | $346.45 |
| Resistance Level | $16.97 | $384.35 |
| Average True Range (ATR) | 0.46 | 8.73 |
| MACD | -0.08 | -1.02 |
| Stochastic Oscillator | 3.82 | 39.19 |
Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck, a full-size SUV, and a delivery van. The company plans to begin selling a midsize SUV in 2026. Total deliveries were over 42,000 in 2025. Rivian is also developing autonomous driving software to be used in its vehicles and for robotaxis on the Uber ride-hailing network.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.